SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

Over the past 15 years, SCT has emerged as a promising treatment option for patients with severe autoimmune diseases (ADs). Mechanistic studies recently provided the proof-of-concept that restoration of immunological tolerance can be achieved by haematopoietic SCT in chronic autoimmunity through era...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, T, Bondanza, A, Muraro, P A, Greco, R, Saccardi, R, Daikeler, T, Kazmi, M, Hawkey, C, Simoes, B P, Leblanc, K, Fibbe, W E, Moore, J, Snarski, E, Martin, T, Hiepe, F, Velardi, A, Toubert, A, Snowden, J A, Farge, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317973/
https://www.ncbi.nlm.nih.gov/pubmed/25387090
http://dx.doi.org/10.1038/bmt.2014.251

Ejemplares similares

Ejemplares similares